CIBC Asset Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-53,043
Closed -$4.01M 1465
2026
Q1
$4.01M Buy
53,043
+742
+1% +$55.8K 0.01% 534
2025
Q4
$3.9M Buy
52,301
+20,912
+67% +$1.53M 0.01% 536
2025
Q3
$2.12M Buy
31,389
+26
+0.1% +$1.73K 0.01% 575
2025
Q2
$2.04M Sell
31,363
-2,772
-8% -$166K 0.01% 567
2025
Q1
$2.11M Sell
34,135
-1,394
-4% -$92.4K 0.01% 563
2024
Q4
$2.56M Buy
35,529
+1,556
+5% +$122K 0.01% 536
2024
Q3
$2.77M Buy
33,973
+2,483
+8% +$199K 0.01% 518
2024
Q2
$2.34M Sell
31,490
-2,148
-6% -$161K 0.01% 522
2024
Q1
$2.62M Sell
33,638
-56
-0.2% -$4.17K 0.01% 514
2023
Q4
$2.41M Sell
33,694
-1,549
-4% -$108K 0.01% 510
2023
Q3
$2.45M Sell
35,243
-416
-1% -$31.4K 0.01% 489
2023
Q2
$2.89M Sell
35,659
-378
-1% -$30.9K 0.01% 466
2023
Q1
$2.91M Buy
36,037
+398
+1% +$32K 0.01% 467
2022
Q4
$2.67M Buy
35,639
+552
+2% +$39.3K 0.01% 485
2022
Q3
$2.26M Buy
35,087
+3,676
+12% +$255K 0.01% 508
2022
Q2
$2.18M Sell
31,411
-39,737
-56% -$2.95M 0.01% 484
2022
Q1
$5.47M Buy
71,148
+47,134
+196% +$3.39M 0.02% 347
2021
Q4
$1.84M Buy
24,014
+931
+4% +$68.4K 0.01% 566
2021
Q3
$1.7M Buy
23,083
+662
+3% +$49.6K 0.01% 565
2021
Q2
$1.5M Sell
22,421
-154
-0.7% -$10.3K 0.01% 591
2021
Q1
$1.68M Sell
22,575
-604
-3% -$45.9K 0.01% 539
2020
Q4
$1.69M Hold
23,179
0.01% 519
2020
Q3
$1.54M Buy
23,179
+445
+2% +$28.2K 0.01% 497
2020
Q2
$1.3M Buy
22,734
+381
+2% +$18.7K 0.01% 507
2020
Q1
$785K Sell
22,353
-1,499
-6% -$71.4K 0.01% 551
2019
Q4
$1.25M Sell
23,852
-340
-1% -$16.9K 0.01% 564
2019
Q3
$1.22M Sell
24,192
-546
-2% -$26.9K 0.01% 550
2019
Q2
$1.19M Sell
24,738
-266
-1% -$12.3K 0.01% 567
2019
Q1
$1.21M Sell
25,004
-1,782
-7% -$80.4K 0.01% 559
2018
Q4
$1.1M Sell
26,786
-12,031
-31% -$494K 0.01% 524
2018
Q3
$1.59M Buy
38,817
+214
+0.6% +$8.65K 0.01% 479
2018
Q2
$1.53M Buy
38,603
+1,504
+4% +$57.8K 0.01% 486
2018
Q1
$1.39M Sell
37,099
-722
-2% -$29.2K 0.01% 497
2017
Q4
$1.62M Buy
37,821
+232
+0.6% +$9.25K 0.01% 460
2017
Q3
$1.38M Buy
37,589
+304
+0.8% +$12.3K 0.01% 486
2017
Q2
$1.69M Buy
37,285
+1,149
+3% +$50.7K 0.01% 436
2017
Q1
$1.54M Buy
36,136
+188
+0.5% +$7.67K 0.01% 462
2016
Q4
$1.44M Buy
35,948
+11,094
+45% +$428K 0.01% 462
2016
Q3
$965K Sell
24,854
-2,046
-8% -$77.2K 0.01% 568
2016
Q2
$931K Buy
26,900
+289
+1% +$10K 0.01% 569
2016
Q1
$918K Buy
26,611
+14,795
+125% +$516K 0.01% 574
2015
Q4
$457K Buy
11,816
+1,734
+17% +$67.5K ﹤0.01% 696
2015
Q3
$395K Buy
10,082
+1,546
+18% +$61.3K ﹤0.01% 708
2015
Q2
$325K Buy
8,536
+204
+2% +$7.14K ﹤0.01% 772
2015
Q1
$275K Buy
8,332
+582
+8% +$17.9K ﹤0.01% 804
2014
Q4
$207K Sell
7,750
-1,043
-12% -$26.9K ﹤0.01% 876
2014
Q3
$214K Buy
+8,793
New +$222K ﹤0.01% 888

Other funds holding HOLX

CIBC Asset Management's HOLX Position: Q2 2026 in Review

CIBC Asset Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 53,043 shares — an estimated $4.01M sold.

CIBC Asset Management first reported a position in HOLX in Q3 2014 and held it in 47 quarters. The position peaked at $5.47M in Q1 2022. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • CIBC Asset Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • CIBC Asset Management sold 53,043 Hologic shares in Q2 2026, an estimated $4.01M.
  • CIBC Asset Management first reported a position in Hologic in Q3 2014 and held it in 47 quarters.
  • CIBC Asset Management's Hologic position peaked at $5.47M in Q1 2022.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.